Búsqueda | Portal de Búsqueda de la BVS Enfermería

1.

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.

Tawbi, Hussein A; Forsyth, Peter A; Algazi, Alain; Hamid, Omid; Hodi, F Stephen; Moschos, Stergios J; Khushalani, Nikhil I; Lewis, Karl; Lao, Christopher D; Postow, Michael A; Atkins, Michael B; Ernstoff, Marc S; Reardon, David A; Puzanov, Igor; Kudchadkar, Ragini R; Thomas, Reena P; Tarhini, Ahmad; Pavlick, Anna C; Jiang, Joel; Avila, Alexandre; Demelo, Sheena; Margolin, Kim.

N Engl J Med ; 379(8): 722-730, 2018 Aug 23.

Artículo en Inglés | MEDLINE | ID: mdl-30134131

2.

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial.

Hodi, Frank Stephen; Chiarion-Sileni, Vanna; Gonzalez, Rene; Grob, Jean-Jacques; Rutkowski, Piotr; Cowey, Charles Lance; Lao, Christopher D; Schadendorf, Dirk; Wagstaff, John; Dummer, Reinhard; Ferrucci, Pier Francesco; Smylie, Michael; Hill, Andrew; Hogg, David; Marquez-Rodas, Ivan; Jiang, Joel; Rizzo, Jasmine; Larkin, James; Wolchok, Jedd D.

Lancet Oncol ; 19(11): 1480-1492, 2018 11.

Artículo en Inglés | MEDLINE | ID: mdl-30361170

3.

Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial.

Weber, Jeffrey S; Gibney, Geoff; Sullivan, Ryan J; Sosman, Jeffrey A; Slingluff, Craig L; Lawrence, Donald P; Logan, Theodore F; Schuchter, Lynn M; Nair, Suresh; Fecher, Leslie; Buchbinder, Elizabeth I; Berghorn, Elmer; Ruisi, Mary; Kong, George; Jiang, Joel; Horak, Christine; Hodi, F Stephen.

Lancet Oncol ; 17(7): 943-955, 2016 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-27269740

4.

Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.

Hodi, F Stephen; Chesney, Jason; Pavlick, Anna C; Robert, Caroline; Grossmann, Kenneth F; McDermott, David F; Linette, Gerald P; Meyer, Nicolas; Giguere, Jeffrey K; Agarwala, Sanjiv S; Shaheen, Montaser; Ernstoff, Marc S; Minor, David R; Salama, April K; Taylor, Matthew H; Ott, Patrick A; Horak, Christine; Gagnier, Paul; Jiang, Joel; Wolchok, Jedd D; Postow, Michael A.

Lancet Oncol ; 17(11): 1558-1568, 2016 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-27622997

5.

Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo-controlled trial.

Neal, Bruce; Perkovic, Vlado; de Zeeuw, Dick; Mahaffey, Kenneth W; Fulcher, Greg; Stein, Peter; Desai, Mehul; Shaw, Wayne; Jiang, Joel; Vercruysse, Frank; Meininger, Gary; Matthews, David.

Am Heart J ; 166(2): 217-223.e11, 2013 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-23895803

6.

Prognostic indicators of disease progression in Duchenne muscular dystrophy: A literature review and evidence synthesis.

Ferizovic, Nermina; Summers, Jessica; de Zárate, Igor Beitia Ortiz; Werner, Christian; Jiang, Joel; Landfeldt, Erik; Buesch, Katharina.

PLoS One ; 17(3): e0265879, 2022.

Artículo en Inglés | MEDLINE | ID: mdl-35333888

7.

Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients.

McDonald, Craig M; Muntoni, Francesco; Penematsa, Vinay; Jiang, Joel; Kristensen, Allan; Bibbiani, Francesco; Goodwin, Elizabeth; Gordish-Dressman, Heather; Morgenroth, Lauren; Werner, Christian; Li, James; Able, Richard; Trifillis, Panayiota; Tulinius, Már.

J Comp Eff Res ; 11(3): 139-155, 2022 02.

Artículo en Inglés | MEDLINE | ID: mdl-34791888

8.

Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study.

Mercuri, Eugenio; Muntoni, Francesco; Osorio, Andrés Nascimento; Tulinius, Már; Buccella, Filippo; Morgenroth, Lauren P; Gordish-Dressman, Heather; Jiang, Joel; Trifillis, Panayiota; Zhu, Jin; Kristensen, Allan; Santos, Claudio L; Henricson, Erik K; McDonald, Craig M; Desguerre, Isabelle.

J Comp Eff Res ; 9(5): 341-360, 2020 04.

Artículo en Inglés | MEDLINE | ID: mdl-31997646

9.

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial.

Ascierto, Paolo A; Long, Georgina V; Robert, Caroline; Brady, Benjamin; Dutriaux, Caroline; Di Giacomo, Anna Maria; Mortier, Laurent; Hassel, Jessica C; Rutkowski, Piotr; McNeil, Catriona; Kalinka-Warzocha, Ewa; Savage, Kerry J; Hernberg, Micaela M; Lebbé, Celeste; Charles, Julie; Mihalcioiu, Catalin; Chiarion-Sileni, Vanna; Mauch, Cornelia; Cognetti, Francesco; Ny, Lars; Arance, Ana; Svane, Inge Marie; Schadendorf, Dirk; Gogas, Helen; Saci, Abdel; Jiang, Joel; Rizzo, Jasmine; Atkinson, Victoria.

JAMA Oncol ; 5(2): 187-194, 2019 02 01.

Artículo en Inglés | MEDLINE | ID: mdl-30422243

10.

Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.

Lucasti, Christopher; Jasovich, Abel; Umeh, Obiamiwe; Jiang, Joel; Kaniga, Koné; Friedland, Ian.

Clin Ther ; 30(5): 868-83, 2008 May.

Artículo en Inglés | MEDLINE | ID: mdl-18555934

11.

Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma.

Weber, Jeffrey S; Hodi, F Stephen; Wolchok, Jedd D; Topalian, Suzanne L; Schadendorf, Dirk; Larkin, James; Sznol, Mario; Long, Georgina V; Li, Hewei; Waxman, Ian M; Jiang, Joel; Robert, Caroline.

J Clin Oncol ; 35(7): 785-792, 2017 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-28068177

12.

Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma.

Sznol, Mario; Ferrucci, Pier Francesco; Hogg, David; Atkins, Michael B; Wolter, Pascal; Guidoboni, Massimo; Lebbé, Celeste; Kirkwood, John M; Schachter, Jacob; Daniels, Gregory A; Hassel, Jessica; Cebon, Jonathan; Gerritsen, Winald; Atkinson, Victoria; Thomas, Luc; McCaffrey, John; Power, Derek; Walker, Dana; Bhore, Rafia; Jiang, Joel; Hodi, F Stephen; Wolchok, Jedd D.

J Clin Oncol ; 35(34): 3815-3822, 2017 Dec 01.

Artículo en Inglés | MEDLINE | ID: mdl-28915085

13.

Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis.

D'Angelo, Sandra P; Larkin, James; Sosman, Jeffrey A; Lebbé, Celeste; Brady, Benjamin; Neyns, Bart; Schmidt, Henrik; Hassel, Jessica C; Hodi, F Stephen; Lorigan, Paul; Savage, Kerry J; Miller, Wilson H; Mohr, Peter; Marquez-Rodas, Ivan; Charles, Julie; Kaatz, Martin; Sznol, Mario; Weber, Jeffrey S; Shoushtari, Alexander N; Ruisi, Mary; Jiang, Joel; Wolchok, Jedd D.

J Clin Oncol ; 35(2): 226-235, 2017 Jan 10.

Artículo en Inglés | MEDLINE | ID: mdl-28056206

14.

Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression: A Subgroup Analysis of a Randomized Clinical Trial.

George, Saby; Motzer, Robert J; Hammers, Hans J; Redman, Bruce G; Kuzel, Timothy M; Tykodi, Scott S; Plimack, Elizabeth R; Jiang, Joel; Waxman, Ian M; Rini, Brian I.

JAMA Oncol ; 2(9): 1179-86, 2016 Sep 01.

Artículo en Inglés | MEDLINE | ID: mdl-27243803

15.

Efficacy and Safety of Nivolumab in Patients With BRAF V600 Mutant and BRAF Wild-Type Advanced Melanoma: A Pooled Analysis of 4 Clinical Trials.

Larkin, James; Lao, Christopher D; Urba, Walter J; McDermott, David F; Horak, Christine; Jiang, Joel; Wolchok, Jedd D.

JAMA Oncol ; 1(4): 433-40, 2015 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-26181250

16.

Efficacy and safety of canagliflozin, an inhibitor of sodium-glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetes.

Neal, Bruce; Perkovic, Vlado; de Zeeuw, Dick; Mahaffey, Kenneth W; Fulcher, Greg; Ways, Kirk; Desai, Mehul; Shaw, Wayne; Capuano, George; Alba, Maria; Jiang, Joel; Vercruysse, Frank; Meininger, Gary; Matthews, David.

Diabetes Care ; 38(3): 403-11, 2015 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-25468945

17.

Reply to M. Horiguchi et al.

Schadendorf, Dirk; Jiang, Joel; Kelleher, Thomas; Postow, Michael A.

J Clin Oncol ; 36(7): 721, 2018 03 01.

Artículo en Inglés | MEDLINE | ID: mdl-29337639

18.

Reply to F. Liang et al.

Weber, Jeffrey S; Jiang, Joel.

J Clin Oncol ; 35(17): 1968, 2017 06 10.

Artículo en Inglés | MEDLINE | ID: mdl-28591545

Portal de Búsqueda de la BVS Enfermería

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: